SCHEDULE: Rosalind Funds Boost InspireMD Stake to 9.4%

Rosalind Advisors and its associated funds, Rosalind Master Fund L.P. and Rosalind Opportunities Fund I L.P., reported a combined beneficial ownership of 9.4% in InspireMD, Inc. common shares, including warrants subject to a blocker provision.

Summary

• Rosalind Advisors, Inc., Steven Salamon, and Gilad Aharon collectively reported beneficial ownership of 10,987,104 common shares of InspireMD, Inc., representing 9.4% of the class.
• This ownership includes 3,905,743 common shares and 7,081,361 shares issuable upon the exercise of warrants.
• Rosalind Master Fund L.P. reported beneficial ownership of 9,485,697 shares, representing 8.4% of the class, comprising 3,508,336 common shares and 5,977,361 shares from warrants.
• Rosalind Opportunities Fund I L.P. reported beneficial ownership of 1,501,407 shares, representing 0.1% of the class, comprising 397,407 common shares and 1,104,000 shares from warrants.
• The percentages reported on the cover page are stated to be based on 41,720,662 common shares outstanding as of August 1, 2025.
• Warrants held by Rosalind Master Fund L.P. and Rosalind Opportunities Fund I L.P. contain a blocker provision, preventing exercise if it would result in beneficial ownership exceeding 9.99% of the Common Stock.
• Due to these blocker provisions, the Reporting Persons were not able to exercise any of the warrants as of the event date (March 31, 2025).
• The beneficial ownership, excluding shares from warrants due to the blocker, was approximately 2,274,990 shares, representing 7.7% of the common stock as of March 12, 2025 (based on 29,689,857 shares outstanding).

Sentiment

Score: 5

Explanation: The filing is a factual disclosure of beneficial ownership, providing no explicit positive or negative sentiment regarding the company's performance or prospects.

Risks

• Beneficial ownership of warrants is subject to a blocker provision, preventing exercise if it would result in ownership exceeding 9.99% of common stock.
• As of the event date, Reporting Persons were unable to exercise warrants due to these blocker provisions, limiting their immediate ability to increase their voting power through warrant conversion.

Future Outlook

NA

Industry Context

NA

Stakeholder Impact

• Shareholders: Disclosure of a significant institutional stake may influence investor perception and trading activity, signaling institutional interest in the company.

Key Dates

Keywords

InspireMD, Common Shares, Schedule 13G, Beneficial Ownership, Rosalind Advisors, Rosalind Master Fund, Rosalind Opportunities Fund, Warrants, Blocker Provision, SEC Filing